# Galectin Therapeutics Inc: filings

GALT · Nasdaq · CIK 1133416 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/galt.md) · [Financials](/companies/galt/financials.md) · [Filings](/companies/galt/filings.md) · [Insiders](/companies/galt/insiders.md)

## Reports and events: 419 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 584, 8-K 280, 10-Q 53, SC 13D/A 34, 4/A 29, 3 25, 144 24, CORRESP 20, UPLOAD 19, 10-K 18, DEF 14A 18, 5 17, EFFECT 17, S-3 11, 424B3 10, POS AM 7, PRE 14A 7, S-8 7, 8-K/A 5, DEFA14A 5, S-3/A 5, ARS 4, CT ORDER 4, D 4, 10-K/A 3, 25-NSE 3, 424B5 3, SC 13D 3, SC 13G 3, SC 13G/A 3, 144/A 2, S-1/A 2, 10-Q/A 1, 3/A 1, 424B1 1, 424B2 1, 5/A 1, 8-A12B/A 1, CERTNAS 1, FWP 1, NO ACT 1, NT 10-K 1, PRER14A 1, REGDEX 1, RW 1, S-1 1, SCHEDULE 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-13 | 12:00 ET | [DEF 14A](/filings/0001140361-26-039379.md) | Proxy statement, period 2026-12-03 | 0001140361-26-039379 |
| 2026-08-14 | 11:55 ET | [8-K](/filings/0001140361-26-032946.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-032946 |
| 2026-08-14 | 11:51 ET | [10-Q](/filings/0001140361-26-032945.md) | Quarterly report, period 2026-06-30 | 0001140361-26-032945 |
| 2026-08-04 | 12:30 ET | [SCHEDULE 13D/A](/filings/0001140361-26-031060.md) | Ownership report, active investor, amended | 0001140361-26-031060 |
| 2026-08-04 | 11:50 ET | [8-K](/filings/0001140361-26-031058.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001140361-26-031058 |
| 2026-06-23 | 11:51 ET | [8-K](/filings/0001140361-26-026031.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-026031 |
| 2026-05-15 | 11:50 ET | [8-K](/filings/0001140361-26-021496.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-021496 |
| 2026-05-15 | 11:46 ET | [10-Q](/filings/0001140361-26-021495.md) | Quarterly report, period 2026-03-31 | 0001140361-26-021495 |
| 2026-03-31 | 11:55 ET | [8-K](/filings/0001140361-26-012158.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-012158 |
| 2026-03-31 | 11:50 ET | [10-K](/filings/0001140361-26-012155.md) | Annual report, period 2025-12-31 | 0001140361-26-012155 |
| 2026-03-17 | 11:50 ET | [8-K](/filings/0001140361-26-009735.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-26-009735 |
| 2026-01-21 | 22:01 ET | [8-K](/filings/0001140361-26-001866.md) | 5.02 Departure or appointment of officers or directors | 0001140361-26-001866 |
| 2026-01-12 | 22:00 ET | [8-K](/filings/0001140361-26-000994.md) | 5.02 Departure or appointment of officers or directors | 0001140361-26-000994 |
| 2025-12-19 | 12:55 ET | [8-K](/filings/0001140361-25-046115.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-25-046115 |
| 2025-12-08 | 13:00 ET | [8-K](/filings/0001140361-25-044711.md) | 5.07 Shareholder vote results | 0001140361-25-044711 |
| 2025-12-03 | 17:00 ET | [8-K](/filings/0001140361-25-044148.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-044148 |
| 2025-11-14 | 12:55 ET | [8-K](/filings/0001140361-25-042118.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-042118 |
| 2025-11-14 | 12:50 ET | [10-Q](/filings/0001140361-25-042116.md) | Quarterly report, period 2025-09-30 | 0001140361-25-042116 |
| 2025-11-10 | 12:56 ET | [8-K](/filings/0001140361-25-041275.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-041275 |
| 2025-10-22 | 12:00 ET | [DEF 14A](/filings/0001140361-25-038875.md) | Proxy statement, period 2025-12-03 | 0001140361-25-038875 |
| 2025-09-08 | 11:56 ET | [8-K](/filings/0001140361-25-034242.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-034242 |
| 2025-08-14 | 11:55 ET | [8-K](/filings/0001140361-25-031041.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-031041 |
| 2025-08-14 | 11:53 ET | [10-Q](/filings/0001140361-25-031039.md) | Quarterly report, period 2025-06-30 | 0001140361-25-031039 |
| 2025-07-09 | 11:55 ET | [8-K](/filings/0001140361-25-025295.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-25-025295 |
| 2025-06-16 | 16:01 ET | [8-K](/filings/0001140361-25-022574.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-022574 |
| 2025-05-15 | 11:55 ET | [8-K](/filings/0001140361-25-019151.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-019151 |
| 2025-05-15 | 11:50 ET | [10-Q](/filings/0001140361-25-019149.md) | Quarterly report, period 2025-03-31 | 0001140361-25-019149 |
| 2025-05-12 | 11:55 ET | [8-K](/filings/0001140361-25-018277.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-018277 |
| 2025-03-31 | 11:55 ET | [8-K](/filings/0001140361-25-011174.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-011174 |
| 2025-03-31 | 11:50 ET | [10-K](/filings/0001140361-25-011169.md) | Annual report, period 2024-12-31 | 0001140361-25-011169 |
| 2025-03-05 | 13:00 ET | [8-K](/filings/0001140361-25-007063.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-007063 |
| 2025-02-18 | 12:55 ET | [8-K](/filings/0001140361-25-004971.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-004971 |
| 2025-01-28 | 13:00 ET | [8-K](/filings/0001140361-25-002125.md) | 5.07 Shareholder vote results | 0001140361-25-002125 |
| 2025-01-23 | 16:15 ET | [8-K](/filings/0001140361-25-001687.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-001687 |
| 2025-01-13 | 13:00 ET | [8-K](/filings/0001140361-25-000879.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-000879 |
| 2024-12-20 | 12:50 ET | [8-K](/filings/0001140361-24-050005.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-050005 |
| 2024-12-03 | 13:03 ET | [DEF 14A](/filings/0001140361-24-048239.md) | Proxy statement, period 2025-01-23 | 0001140361-24-048239 |
| 2024-11-14 | 13:00 ET | [8-K](/filings/0001140361-24-046730.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-046730 |
| 2024-11-14 | 12:55 ET | [8-K](/filings/0001140361-24-046728.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-046728 |
| 2024-11-14 | 12:51 ET | [10-Q](/filings/0001140361-24-046726.md) | Quarterly report, period 2024-09-30 | 0001140361-24-046726 |
| 2024-09-09 | 12:00 ET | [8-K](/filings/0001140361-24-040509.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-040509 |
| 2024-08-13 | 11:55 ET | [8-K](/filings/0001140361-24-036938.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-036938 |
| 2024-08-13 | 11:50 ET | [10-Q](/filings/0001140361-24-036937.md) | Quarterly report, period 2024-06-30 | 0001140361-24-036937 |
| 2024-08-01 | 11:50 ET | [8-K](/filings/0001140361-24-035212.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-24-035212 |
| 2024-05-15 | 11:55 ET | [8-K](/filings/0001140361-24-026106.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-026106 |
| 2024-05-15 | 11:50 ET | [10-Q](/filings/0001140361-24-026105.md) | Quarterly report, period 2024-03-31 | 0001140361-24-026105 |
| 2024-03-29 | 11:55 ET | [8-K](/filings/0001140361-24-016454.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-016454 |
| 2024-03-29 | 11:51 ET | [10-K](/filings/0001140361-24-016452.md) | Annual report, period 2023-12-31 | 0001140361-24-016452 |
| 2023-12-11 | 21:15 ET | [8-K](/filings/0001140361-23-057155.md) | 5.07 Shareholder vote results | 0001140361-23-057155 |
| 2023-12-07 | 16:42 ET | [8-K](/filings/0001140361-23-056586.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-23-056586 |

Page 1 of 9. [Older](/companies/galt/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.